Call For Abstracts | ISHA Annual Scientific Meeting 2012

Coming Soon

Sponsored by Medical Education Resources, Inc. and MCJ Consulting.

Call-for-Abstracts

Abstract Submission Opens: January 1, 2012
Abstract Submission Closes: May 1, 2012

Online Abstract Submission Instructions

Abstract categories are:

Basic Science
Extra Articular Hip Endoscopy
General Hip Arthroscopy
Impingement
Chondral and Labral Treatment
Advanced / Innovative Hip Arthroscopic Techniques
Post Operative Management
Other

Authors need to have the following information readily available when submitting an abstract:

Complete contact information for the Presenting and the Corresponding authors including the institution of research.
Provide the abstract title in proper case for publishing.
Submit the abstract text as plain text into a text box located in the online application. Please note, graphics and tables are not accepted.
Complete the Financial Disclosure Statement, American Food and Drug Administration (FDA) statement, and Copyright License Agreement on behalf of all authors.
Author warranty: authors are must read and abide by the guidelines below in order to be considered for presentation.

General Guidelines

The same First Author may submit a maximum of six abstracts for consideration at the ISHA Annual Scientific Meeting 2012. Authors do not have to be ISHA members to submit an abstract.
Persons submitting an abstract (Corresponding Author) to ISHA do so with the understanding that they and all the authors listed on the abstract will abide by the conditions, deadlines, policies and decisions of the ISHA Executive Committee and Program Committee.
Abstracts are only accepted for consideration via the online abstract application form. Abstracts submitted to the ISHA Program Office in any other fashion will not be considered for presentation.
The deadline for submission is May 1, 2012 at 11:59 P.M. Pacific Standard Time. Abstracts will not be accepted after that date.
If the abstract is accepted for podium presentation, all presenters must speak in English, and be prepared to answer questions from the audience in English.
Please indicate the preference of presentation method for the submitted abstract: paper/podium or electronic poster (e-poster) presentation. The ISHA Program Committee will make final decisions on the mode of presentation however; efforts will be made to comply with the stated preference.
All presenters, co-authors, faculty members, etc. who will attend the ISHA Annual Scientific Meeting 2012 are expected to register for the meeting and pay all registration and travel costs. No exceptions are made. If attendance is dependent on outside funding, please secure financial assistance before submitting an abstract.
Persons submitting an abstract to ISHA must complete a Financial Disclosure Statement and an American Food and Drug Administration statement.
Although ISHA is an international society, it receives continuing medical education accreditation and is planned and implemented with the essential areas and policies of the Accreditation Council for Continuing Medical Education (ACCME). ISHA does not view the existence of disclosed interest or investments as necessarily implying bias or decreasing the value of the presentation. These disclosures will not be seen or taken into consideration when the abstract is considered for presentation.
Persons submitting an abstract to ISHA must complete a Copyright License Agreement so the chosen abstracts can be published in the ISHA final program; the ISHA Annual Scientific Meeting 2012 proceedings; and on the ISHA website.

Grading Criteria

Abstract Review will be based on the following criteria:

Scientific Merit (0 - 6)
- Is the problem clearly stated?
- Are the statistics sound?
- Are there adequate numbers of subjects?
- How is the methodology {are there controls, is this prospective vs. retrospective}?
- Is the abstract clear / well written and are the results clear?
- Are the conclusions supported by the results?
Originality of project (0-2)
Clinical Usefulness (0-2)
Level of Interest to ISHA Members (0-2)